These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20227786)

  • 1. Problems with pseudomonas.
    McLellan E; Tomlin K
    J Hosp Infect; 2010 May; 75(1):75-6. PubMed ID: 20227786
    [No Abstract]   [Full Text] [Related]  

  • 2. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we be afraid of the Green Monster?
    Rumbaugh K
    Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
    [No Abstract]   [Full Text] [Related]  

  • 4. Outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
    Durojaiye OC; Carbarns N; Murray S; Majumdar S
    J Hosp Infect; 2011 Jun; 78(2):154-5. PubMed ID: 21507523
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlling the clonal spread of Pseudomonas aeruginosa infection.
    Pereira GH; Levin AS; Oliveira HB; Moretti ML
    Infect Control Hosp Epidemiol; 2008 Jun; 29(6):549-52. PubMed ID: 18476775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
    Paez J; Levin AS; Fu L; Basso M; Fonseca GH; Dulley FL; Rossi F; Guimarães T; Costa SF
    J Hosp Infect; 2011 Jan; 77(1):76-7. PubMed ID: 21030111
    [No Abstract]   [Full Text] [Related]  

  • 7. Nosocomial outbreak of meropenem resistant Pseudomonas aeruginosa infections in a cancer centre.
    Krcméry V; Trupl J
    J Hosp Infect; 1994 Jan; 26(1):69-71. PubMed ID: 7910185
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa.
    Eagye KJ; Kuti JL; Nicolau DP
    Infect Control Hosp Epidemiol; 2009 Aug; 30(8):746-52. PubMed ID: 19583513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit.
    Nagao M; Iinuma Y; Igawa J; Saito T; Yamashita K; Kondo T; Matsushima A; Takakura S; Takaori-Kondo A; Ichiyama S
    J Hosp Infect; 2011 Sep; 79(1):49-53. PubMed ID: 21722990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for both antibiotic cycling and stringent environmental controls to prevent Pseudomonas infections.
    Curtis L
    Surg Infect (Larchmt); 2009 Apr; 10(2):163. PubMed ID: 19388838
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of Pseudomonas aeruginosa in the etiology of infectious complications in cancer patients].
    Smolianskaia AZ; Sakaian NN; Grinenko GI; Anan'ev VS; Dronova OM
    Vopr Onkol; 1986; 32(12):33-7. PubMed ID: 3099468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
    Knoester M; de Boer MG; Maarleveld JJ; Claas EC; Bernards AT; de Jonge E; van Dissel JT; Veldkamp KE
    Clin Microbiol Infect; 2014 Apr; 20(4):O207-15. PubMed ID: 24707852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intensive infection control team activities on the acquisition of methicillin-resistant Staphylococcus aureus, drug-resistant Pseudomonas aeruginosa and the incidence of Clostridium difficile-associated disease.
    Suzuki H; Senda J; Yamashita K; Tokuda Y; Kanesaka Y; Kotaki N; Ishihara H; Ishikawa H
    J Infect Chemother; 2013 Dec; 19(6):1047-52. PubMed ID: 23715827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa.
    Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ
    J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes.
    Harris AD; Jackson SS; Robinson G; Pineles L; Leekha S; Thom KA; Wang Y; Doll M; Pettigrew MM; Johnson JK
    Infect Control Hosp Epidemiol; 2016 May; 37(5):544-8. PubMed ID: 26832307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak investigation of Pseudomonas aeruginosa infections in a neonatal intensive care unit.
    Weng MK; Brooks RB; Glowicz J; Keckler MS; Christensen BE; Tsai V; Mitchell CS; Wilson LE; Laxton R; Moulton-Meissner H; Fagan R
    Am J Infect Control; 2019 Sep; 47(9):1148-1150. PubMed ID: 31047691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of resistant gram-negative bacilli in a burns unit.
    Fujita K; Lilly HA; Ayliffe GA
    J Hosp Infect; 1982 Mar; 3(1):29-37. PubMed ID: 6177731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pseudomonas aeruginosa].
    Ono Y
    Nihon Rinsho; 2002 Nov; 60(11):2150-5. PubMed ID: 12440121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
    Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
    J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.